Shopping Cart
- Remove All
- Your shopping cart is currently empty
AN7973 blocks intracellular parasite development and inhibits Cryptosporidium growth. It is orally active, possesses favorable safety, stability, and PK parameters.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $332 | 6-8 weeks | |
25 mg | $1,080 | 6-8 weeks | |
50 mg | $1,410 | 6-8 weeks | |
100 mg | $1,990 | 6-8 weeks | |
1 mL x 10 mM (in DMSO) | $333 | 6-8 weeks |
Description | AN7973 blocks intracellular parasite development and inhibits Cryptosporidium growth. It is orally active, possesses favorable safety, stability, and PK parameters. |
In vivo | AN7973 (oral gavage; 5-25 mg/kg; once daily) effectively treats both acute and chronic C. parvum infections in murine models by rapidly eliminating the pathogen in vivo. Additionally, AN7973 (oral gavage; 5 mg/kg, 10 mg/kg, 6.67 mg/kg; once daily, twice daily, three times daily) reduces C. parvum fecal shedding, diarrhea, and dehydration in a neonatal calf model of cryptosporidiosis. |
Molecular Weight | 381.62 |
Formula | C19H17BClN3O3 |
Cas No. | 1620899-32-2 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.